Medical Writing Patient-reported outcomes Measuring quality of life – theoretical background

Volume 27, Issue 4 - Patient-reported outcomes

Measuring quality of life – theoretical background

Abstract

Patient-centred medicine has come out of the increasing importance of patients’ voices in disease management. As part of this, health related quality of life (HR-QoL) has become an important part of assessing treatment outcome and the quality of patient management. In this article, I discuss health as one of the determinants of a good quality of life and how to interpret and present HR-QoL measures and thereby place them in a clinical context. Key issues covered include the theoretical HR-QoL models underlying HRQoL measures, how the measures are constructed, how they work, and how to interpret the scores they generate.

Download the full article

References

  1. The Economist Intelligence Unit’s qualityof- life index. 2005 [cited 2018 Aug 11]. Available from: Available from: https://www.economist.com/media/pdf/ QUALITY_OF_LIFE.pdf.
  2. World Health Organization (WHO) 1948 World Health Organization constitution Preamble to the Constitution of the World Health Organization as adopted by the International Health Conference, New York, 19 June – 22 July 1946; signed on 22 July 1946 by the representatives of 61 States (Official Records of the World Health Organization, no. 2, p. 100) and entered into force on 7 April 1948; Basic Documents, Forty-fifth edition, Supplement. October 2006 [cited 2018 Aug 11]. Available from: Available from: http://www.who.int/governance/eb/who _constitution_en.pdf.
  3. Berger ML, Bingefors K, Hedblom EC, Pashos CL, Torrance GW, Dix Smith M, editors. Health care, cost, quality and outcomes: ISPOR book of terms. 1st ed. Lawrenceville: International Society for Pharmacoeconomics and Outcomes Research; 2003. Available from: http://
  4. Fayers PM, Machin D. Quality of life, assessment, analysis and interpretation. 1st ed. Chichester, New York, Weinheim, Brisbane, Singapore, Toronto: John Wiley and Sons Ltd; 2001. Available from: http://
  5. Kind P. Methodological issues in the assessment of quality of life. In: Abs R, Feldt-Rasmussen U, editors. Growth Hormone Deficiency in Adults: 10 Years of KIMS. Oxford: Oxford PharmaGenesis; 2004. p. 189–98. Available from: http://
  6. Ware JE, Jr. The status of health assessment. Annu Rev Public Health. 1995;16:327–54. Available from: http://
  7. Wilson IB & Cleary PD. Linking clinical variable with health-related quality of life. JAMA. 1995;273(1):59–65. Available from: http://
  8. Snyder AR, Parsons JT, Valovich McLeod TC, Curtis Bay R, Michener LA, Sauers EL. Using disablement models and clinical outcomes assessment to enable evidencebased athletic training practice, Part I: Disablement Models. J Athl Train. 2008;43(4):428–36. Available from: http://
  9. Calman KC. Quality of life in cancer patients: an hypothesis. J Med Ethics. 1984;10:24–127. Available from: http://
  10. Hunt SM, McKenna SP. The QLDS: a scale for the measurement of quality of life in depression. Health Policy. 1992;22:307–19. Available from: http://
  11. Galen Research, Measures Database [cited 2018 Aug 12]. Available from: Available from: http://www.galen-research.com/measuresdatabase/
  12. Kołtowska-Häggström M, Mattsson AF, Shalet SM. Assessment of quality of life in adult patients with GH deficiency: KIMS contribution to clinical practice and pharmacoeconomic evaluations. Eur J Endocrinol. 2009;161:S51-S64. Available from: http://
  13. Hunt SM, McKenna SP, McEwen J, Williams J, Papp E. The Nottingham health profile: subjective health status and medical consultations. Soc Sci Med. 1981;15:221–9. Available from: http://
  14. Likert RA. Technique for the measurement of attitudes. Arch Psychol. 1932;140:1–55. Available from: http://
  15. Priestman TJ, Baum M. Evaluation of quality of life in patients receiving treatment for advanced breast cancer. Lancet. 1976;1(7965):899–900. Available from: http://
  16. Juniper EF, Guyatt GH, Jaeschke R. How to develop and validate a new health-related quality of life instrument. In: Spilker B, editor. Quality of life and pharma - coeconomics in clinical trials. Philadelphia, New York, 2nd ed. Lippincott-Raven Publishers; 1996. Available from: http://
  17. Koltowska-Haggstrom M. Quality of life and growth hormone deficiency in adult patients in clinical evaluation and health economic assessment. Pediatr Endocrinol Diab Metab. 2009;15(3)203–9. Available from: http://
  18. Woodhouse LJ, Mukherjee A, Shalet SM, Ezzat S. The influence of growth hormone status on physical impairments, functional limitations, and health-related quality of life in adults. Endocrine Rev. 2006;27(3): 287–317. Available from: http://

Search

Articles

Patient reported outcomes
President's Message
EMWA News
Measuring health outcomes: The foundation of contemporary healthcare decision-making
Measuring quality of life – theoretical background
Quality of life measures – an overview
Publication planning and patient-reported outcomes: Demonstrating value in a multi-stakeholder era
Patient-reported outcome measure translation: An overview
Systematic hospital collection of patient-reported outcome data via patient apps
The PROMIS of electronic patient-reported outcomes
Interview with Professor Matthias Rose on developing patient-reported outcomes and the PROMIS initiative
The UK pharmaceutical industry braces for Brexit, be it mild, severe, or doomsday
Awareness of medical writing as a profession and its career prospects
Estimands – closing the gap between study design and analysis
Protecting the rights of clinical trial patients through disclosure: The significance of plain language
News from the EMA
Regulatory Matters & Regulatory Public Disclosure
Medical Communications
Medical Devices
Journal Watch
In the Bookstores
Good Writing Practice
Getting Your Foot In The Door
My First Medical Writing
Out on Our Own

Member Login

Links

The Write Stuff Archive Contact Instructions for Authors Article Template (Word) Journal Policies

Editoral Board

Editor-in-Chief

Raquel Billiones

Co-Editors

Evguenia Alechine

Jonathan Pitt

Managing Editor

Victoria White

Associate Editors

Anuradha Alahari

Jennifer Bell

Nicole Bezuidenhout

Claire Chang

Barbara Grossman

Sarah Milner

John Plant

Sampoorna Rappaz

Amy Whereat

Section Editors

Daniela Kamir

AI/Automation

Jennifer Bell

Biotechnology

Nicole Bezuidenhout 

Digital Communication

Somsuvro Basu

EMWA News 

Ana Sofia Correia 

Gained in Translation

Ivana Turek

Getting Your Foot in the Door

Wendy Kingdom / Amy Whereat

Good Writing Practice

Alison McIntosh 

In the Bookstores

Maria Kołtowska-Häggström

Lingua Franca and Beyond

Maddy Dyer

Publications

Lisa Chamberlain-James

Medical Communications/Writing for Patients

Payal Bhatia

Medical Devices

Evguenia Alechine

My First Medical Writing

Anuradha Alahari

News from the EMA

Adriana Rocha

Out on Our Own

Tiziana von Bruchhausen

Pharmacovigilance

Clare ChangZuo Yen Lee 

Regulatory Matters

Sam Hamilton

Regulatory Public Disclosure

Claire Gudex

Teaching Medical Writing

Louisa Ludwig-Begall / Sarah Kabani

The Crofter: Sustainable Communications

Louisa Marcombes

Veterinary Writing

Editors Emeritus

Elise Langdon-Neuner

Phil Leventhal

Layout Designer

Chris Monk